Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) - Total Assets

Latest as of September 2025: CN¥16.67 Billion CNY ≈ $2.44 Billion USD

Based on the latest financial reports, Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) holds total assets worth CN¥16.67 Billion CNY (≈ $2.44 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 002223 net asset value for net asset value and shareholders' equity analysis.

Jiangsu Yuyue Medical Equipment & Supply Co Ltd - Total Assets Trend (2005–2024)

This chart illustrates how Jiangsu Yuyue Medical Equipment & Supply Co Ltd's total assets have evolved over time, based on quarterly financial data.

Jiangsu Yuyue Medical Equipment & Supply Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Jiangsu Yuyue Medical Equipment & Supply Co Ltd's total assets of CN¥16.67 Billion consist of 59.2% current assets and 40.8% non-current assets.

Asset Category Amount (CNY) % of Total Assets
Cash & Equivalents CN¥0.00 42.3%
Accounts Receivable CN¥862.63 Million 5.5%
Inventory CN¥1.44 Billion 9.2%
Property, Plant & Equipment CN¥0.00 0.0%
Intangible Assets CN¥492.12 Million 3.2%
Goodwill CN¥1.08 Billion 6.9%

Asset Composition Trend (2005–2024)

This chart illustrates how Jiangsu Yuyue Medical Equipment & Supply Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Jiangsu Yuyue Medical Equipment & Supply market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Jiangsu Yuyue Medical Equipment & Supply Co Ltd's current assets represent 59.2% of total assets in 2024, a decrease from 71.4% in 2005.
  • Cash Position: Cash and equivalents constituted 42.3% of total assets in 2024, up from 4.7% in 2005.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, a decrease from 19.0% in 2005.
  • Asset Diversification: The largest asset category is inventory at 9.2% of total assets.

Jiangsu Yuyue Medical Equipment & Supply Co Ltd Competitors by Total Assets

Key competitors of Jiangsu Yuyue Medical Equipment & Supply Co Ltd based on total assets are shown below.

Company Country Total Assets
Shenzhen New Industries Biomedical
SHE:300832
China CN¥9.58 Billion
Medacta Group SA
SW:MOVE
Switzerland CHF860.76 Million
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
China CN¥1.86 Billion
Emvision Medical Devices Ltd
AU:EMV
Australia AU$15.57 Million
Implanet SA
PA:ALIMP
France €16.53 Million
BBS-Bioactive Bone Substitutes Oyj
HE:BONEH
Finland €9.37 Million
Cochlear Ltd
AU:COH
Australia AU$2.83 Billion
4DMEDICAL Ltd
AU:4DX
Australia AU$139.55 Million

Jiangsu Yuyue Medical Equipment & Supply Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 3.69 3.87 2.28
Quick Ratio 3.25 3.37 1.86
Cash Ratio 0.00 0.00 0.00
Working Capital CN¥7.46 Billion CN¥6.80 Billion CN¥2.99 Billion

Jiangsu Yuyue Medical Equipment & Supply Co Ltd - Advanced Valuation Insights

This section examines the relationship between Jiangsu Yuyue Medical Equipment & Supply Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.46
Latest Market Cap to Assets Ratio 0.28
Asset Growth Rate (YoY) -2.0%
Total Assets CN¥15.65 Billion
Market Capitalization $4.40 Billion USD

Valuation Analysis

Below Book Valuation: The market values Jiangsu Yuyue Medical Equipment & Supply Co Ltd's assets below their book value (0.28x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Jiangsu Yuyue Medical Equipment & Supply Co Ltd's assets decreased by 2.0% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Jiangsu Yuyue Medical Equipment & Supply Co Ltd (2005–2024)

The table below shows the annual total assets of Jiangsu Yuyue Medical Equipment & Supply Co Ltd from 2005 to 2024.

Year Total Assets Change
2024-12-31 CN¥15.65 Billion
≈ $2.29 Billion
-2.01%
2023-12-31 CN¥15.97 Billion
≈ $2.34 Billion
+5.78%
2022-12-31 CN¥15.10 Billion
≈ $2.21 Billion
+25.82%
2021-12-31 CN¥12.00 Billion
≈ $1.76 Billion
+18.89%
2020-12-31 CN¥10.09 Billion
≈ $1.48 Billion
+26.68%
2019-12-31 CN¥7.97 Billion
≈ $1.17 Billion
+15.26%
2018-12-31 CN¥6.91 Billion
≈ $1.01 Billion
+4.27%
2017-12-31 CN¥6.63 Billion
≈ $969.97 Million
+13.99%
2016-12-31 CN¥5.82 Billion
≈ $850.94 Million
+98.75%
2015-12-31 CN¥2.93 Billion
≈ $428.15 Million
+36.83%
2014-12-31 CN¥2.14 Billion
≈ $312.90 Million
+17.92%
2013-12-31 CN¥1.81 Billion
≈ $265.35 Million
+17.77%
2012-12-31 CN¥1.54 Billion
≈ $225.32 Million
+18.73%
2011-12-31 CN¥1.30 Billion
≈ $189.78 Million
+21.95%
2010-12-31 CN¥1.06 Billion
≈ $155.62 Million
+66.62%
2009-12-31 CN¥638.29 Million
≈ $93.40 Million
+42.01%
2008-12-31 CN¥449.45 Million
≈ $65.77 Million
+65.66%
2007-12-31 CN¥271.32 Million
≈ $39.70 Million
-31.04%
2006-12-31 CN¥393.46 Million
≈ $57.57 Million
+23.02%
2005-12-31 CN¥319.82 Million
≈ $46.80 Million
--

About Jiangsu Yuyue Medical Equipment & Supply Co Ltd

SHE:002223 China Medical Devices
Market Cap
$4.40 Billion
CN¥30.07 Billion CNY
Market Cap Rank
#3950 Global
#666 in China
Share Price
CN¥30.00
Change (1 day)
+0.91%
52-Week Range
CN¥29.08 - CN¥45.40
All Time High
CN¥45.40
About

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. engages provision of home medical devices, medical clinical products, and related services in China and internationally. It offers respiratory solutions, including PAP therapy, oxygen concentrators, nebulizers, high flow oxygen therapy, and airway clearances; diabetes management solutions; medical diagnostic devices, such as blood pressure monito… Read more